Review



sap97 mouse k64 15 igg1  (NeuroMab)


Bioz Verified Symbol NeuroMab is a verified supplier
Bioz Manufacturer Symbol NeuroMab manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    NeuroMab sap97 mouse k64 15 igg1
    Sap97 Mouse K64 15 Igg1, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-SAP97+Antibody/pm40111234__ja5c00772_si_001-164-26-25
    Average 93 stars, based on 47 article reviews
    sap97 mouse k64 15 igg1 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Schizophrenia-associated SAP97 mutations increase glutamatergic synapse strength in the dentate gyrus and impair contextual episodic memory in rats.
    Article Snippet: .. Following the transfer, membranes were cut and analyzed by western blot with antibodies against SAP97 (1:500, Neuromab, Cat#75-030) and β-actin (1:1000, Cell Signaling Technology, Cat#4970S). ..

    Article Title: Schizophrenia-associated SAP97 mutations increase glutamatergic synapse strength in the dentate gyrus and impair contextual episodic memory in rats
    Article Snippet: .. Following the transfer, membranes were cut and analyzed by western blot with antibodies against SAP97 (1:500, Neuromab, Cat#75-030) and β-actin (1:1000, Cell Signaling Technology, Cat#4970S). ..

    other:

    Article Title: eSylites: Synthetic Probes for Visualization and Topographic Mapping of Single Excitatory Synapses.
    Article Snippet: Target Protein Species Clone Subtype Catalogue # Supplier PSD-95 Mouse K28/43 IgG2a 75-028 NeuroMab PSD-93 Mouse N18/30 IgG1 75-057 NeuroMab SAP102 Mouse N19/2 IgG1 75-058 NeuroMab SAP97 Mouse K64/15 IgG1 75-030 NeuroMab GluA1 Mouse N355/1 IgG1 75-327 NeuroMab GluN2B Mouse N59/36 IgG2b 75-101 NeuroMab MAP2 Rabbit D5G1 8707S Cell Signaling 331 332 Appendix 1.

    Article Title: 4.1N and SAP97 regulate different phases of AMPA receptor intracellular transport
    Article Snippet: Anti-GFP from Sigma Aldrich (ref: 11814460001), anti-Ds-Red from Ozyme (ref: 632496), anti-myc from Merck Millipore (ref: 6549), anti-4.1N from BD Biosciences (ref: 611836) anti SAP97 from NeuroMab (ref:75-030), anti-GluA1 from NeuroMab (ref: 75-327).

    Bioprocessing:

    Article Title: Identification of MAGUK scaffold proteins as intracellular binding partners of synaptic adhesion protein Slitrk2.
    Article Snippet: AntiHA.11 epitope tag antibody was obtained from BioLegend, and monoclonal myc antibody clone 9E.10 was obtained from BioRad. .. Mouse monoclonal antibodies against PSD-95, PSD-93, pan-MAGUK, SAP97, and SAP102 were obtained from the NIH NeuroMab Facility at UCDavis. .. Goat anti-rabbit Alexa 488 and goat anti-mouse Alexa 594 were obtained from Abcam.



    Similar Products

    93
    NeuroMab sap97 mouse k64 15 igg1
    Sap97 Mouse K64 15 Igg1, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-SAP97+Antibody/pm40111234__ja5c00772_si_001-164-26-25
    Average 93 stars, based on 1 article reviews
    sap97 mouse k64 15 igg1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Enzo Biochem mouse anti-sap97
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Mouse Anti Sap97, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/mouse+anti+sap97/pmc10000963-72-64-67
    Average 90 stars, based on 1 article reviews
    mouse anti-sap97 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mouse anti sap97
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Mouse Anti Sap97, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/SAP+97+Antibody/pm36624510-116-46-50
    Average 93 stars, based on 1 article reviews
    mouse anti sap97 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    99
    Danaher Inc sap97
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Sap97, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Abcam+Goat+Anti-Mouse+IgG+H%26L/pm33107046-108-51-55
    Average 99 stars, based on 1 article reviews
    sap97 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    93
    NeuroMab mouse anti sap102
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Mouse Anti Sap102, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-SAP97+Antibody/pmc07510947__20jFjrXAnOTWfgBBHiJuATnkFjLOHRJ4KxTVSCXk1dY1tzC4V0yhMPnQmb0hGz1n87AaB1d0Idqj0DvFAJIZQ2bdUyGXNzB9xpOyXK8d-29-46-48
    Average 93 stars, based on 1 article reviews
    mouse anti sap102 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    NeuroMab mouse antisap97
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Mouse Antisap97, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-SAP97+Antibody/pmc07510947__20jFjrXAnOTWfgBBHiJuATnkFjLOHRJ4KxTVSCXk1dY1tzC4V0yhMPnQmb0hGz1n87AaB1d0Idqj0DvFAJIZQ2bdUyGXNzB9xpOyXK8d-29-41-43
    Average 93 stars, based on 1 article reviews
    mouse antisap97 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    96
    NeuroMab mouse anti sap97
    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing <t>SAP97</t> expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).
    Mouse Anti Sap97, supplied by NeuroMab, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-PSD-95+Antibody/pmc07510947__20jFjrXAnOTWfgBBHiJuATnkFjLOHRJ4KxTVSCXk1dY1tzC4V0yhMPnQmb0hGz1n87AaB1d0Idqj0DvFAJIZQ2bdUyGXNzB9xpOyXK8d-17-48-50
    Average 96 stars, based on 1 article reviews
    mouse anti sap97 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    93
    NeuroMab staining against sap97 mouse anti sap97
    Exposure to the forced swim test for two consecutive days drastically reduces Dlg4 transcription. Hippocampal expression of Dlg1 , Dlg4 , Gria1 , and Gria2 mRNA (coding for <t>SAP97,</t> PSD-95, GluA1, and GluA2 respectively) relative to two reference genes ( Pgk1 and B2m ) after one (FST1; N = 8) or two (FST2; N = 7) swim test exposures relative to untreated wild type mice (CTRL; N = 9) (see Table and Fig. for details on primer pairs). Red circles indicate individual data points. Asterisks indicate statistical significance (Holm-Bonferroni corrected) compared to CTRL mice: ***P < 0.001 and n.s. indicates lack of significance compared to CTRL.
    Staining Against Sap97 Mouse Anti Sap97, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti-sap97/Anti-SAP97+Antibody/pmc06773768-53-1-7
    Average 93 stars, based on 1 article reviews
    staining against sap97 mouse anti sap97 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing SAP97 expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).

    Journal: Cells

    Article Title: Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals

    doi: 10.3390/cells12050758

    Figure Lengend Snippet: Modulation of ADAM10 in human TDI and FXS fibroblasts. ( A ) Schematic representation of the mechanism of action of the TAT-Pro peptide (image created in BioRender.com). ( B ) Left, representative Western blot showing SAP97 expression in TDI and FXS fibroblasts. Right, the bar plot shows the quantification of SAP97 levels in TDI and FXS fibroblasts (TDI n = 8; FXS n = 8). Error bars represent the SEM (** p < 0.01, Mann–Whitney test). ( C ) Left, representative Western blots showing the levels of sAPPα in non-treated fibroblasts (NT), treated with the control peptide (Ala) or with the specific peptide (Pro). Right, the bar plots show the quantification of sAPPα normalized to Coomassie staining (TDI n = 6, FXS n = 10). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F (1, 42) = 61.97 *** p < 0.001; treatment effect F(2, 42) = 2.866 p > 0.05; interaction effect F(2, 42) = 4.422) (*** p < 0.001 NT TDI vs. NT FXS; *** p < 0.001 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test). ( D ) Left, representative Western blot showing the levels of puromycin incorporation in fibroblasts NT, treated with the Ala or Pro peptides. Right, the bar plots show the quantification of puromycin normalized to Coomassie staining in TDI and FXS fibroblasts expressing regular or high levels of protein synthesis (TDI n = 6, FXS high n = 5; FXS regular n = 5). Error bars represent the SEM (Two-way ANOVA analysis: genotype effect F(2, 39) = 34.87 *** p < 0.001; treatment effect F(2, 39) = 0.4527 p > 0.05; interaction effect F(4, 39) = 2.008 p > 0.05) (*** p < 0.001 NT TDI vs. NT FXS; ** p < 0.01 TAT-Ala TDI vs. TAT-Ala FXS, Sidak’s multiple comparisons test).

    Article Snippet: Membranes were incubated using the following specific antibodies, including mouse anti-puromycin (1:500, DSHB), mouse anti-Vinculin (1:2000, Merck), mouse anti-GAPDH (1:2000, Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA), rabbit anti-APP (1:2000, Merck), rabbit anti-ADAM10 (1:500, Abcam, Cambridge, UK), mouse anti-sAPPα (1:500, IBL America, Minneapolis, MN, USA), rabbit anti-OCT3/4 (1:1000, Santa Cruz Biotechnology, Dallas, TX, USA), mouse anti-MAP2 (1:2000, Merck), mouse anti-Nestin (1:1000 Santa Cruz Biotechnology), mouse anti-SAP97 (1:1000, ENZO Life Sciences, Farmingdale, NY, USA) and rabbit anti-FMRP (1:1000, produced in house PZ1 [ ]), HRP-conjugated anti-rabbit and anti-mouse secondary antibodies (1:5000, Cell Signaling Technology, Danvers, MA, USA).

    Techniques: Western Blot, Expressing, MANN-WHITNEY, Staining

    Exposure to the forced swim test for two consecutive days drastically reduces Dlg4 transcription. Hippocampal expression of Dlg1 , Dlg4 , Gria1 , and Gria2 mRNA (coding for SAP97, PSD-95, GluA1, and GluA2 respectively) relative to two reference genes ( Pgk1 and B2m ) after one (FST1; N = 8) or two (FST2; N = 7) swim test exposures relative to untreated wild type mice (CTRL; N = 9) (see Table and Fig. for details on primer pairs). Red circles indicate individual data points. Asterisks indicate statistical significance (Holm-Bonferroni corrected) compared to CTRL mice: ***P < 0.001 and n.s. indicates lack of significance compared to CTRL.

    Journal: Scientific Reports

    Article Title: Quantitative analysis of Gria1 , Gria2 , Dlg1 and Dlg4 expression levels in hippocampus following forced swim stress in mice

    doi: 10.1038/s41598-019-50689-w

    Figure Lengend Snippet: Exposure to the forced swim test for two consecutive days drastically reduces Dlg4 transcription. Hippocampal expression of Dlg1 , Dlg4 , Gria1 , and Gria2 mRNA (coding for SAP97, PSD-95, GluA1, and GluA2 respectively) relative to two reference genes ( Pgk1 and B2m ) after one (FST1; N = 8) or two (FST2; N = 7) swim test exposures relative to untreated wild type mice (CTRL; N = 9) (see Table and Fig. for details on primer pairs). Red circles indicate individual data points. Asterisks indicate statistical significance (Holm-Bonferroni corrected) compared to CTRL mice: ***P < 0.001 and n.s. indicates lack of significance compared to CTRL.

    Article Snippet: For staining against SAP97: mouse anti-SAP97 1:500 (NeuroMab K64/15, Lot#75-030), mouse anti-GAPDH 1:10,000 (Sigma-Aldrich G8795, Lot#010M4814), mouse anti-β-actin 1:1,000 (Santa-Cruz sc-47778, Lot#C1510).

    Techniques: Expressing

    Forced swim stress does not significantly alter protein levels in hippocampus. ( A ) Hippocampal SAP97, PSD-95, and GluA1 levels relative to β-actin and Gapdh after one (FST1; N = 3 for SAP97 homogenates, N = 10 for all others) or two (FST2; N = 7 for SAP97 synaptoneurosomes, N = 8 for SAP97 homogenates, N = 11 for all others) swim test exposures relative to untreated wild type mice (CTRL; N = 7 for SAP97 homogenates, N = 9 for all others). ( B ) Protein levels (relative to β-actin and Gapdh) in synaptoneurosomal fractions prepared from hippocampal homogenates (CTRL, N = 9; FST1, N = 10; FST2; N = 7–11). Note that differences in sample size are a result of samples being removed when the number of available replicates was below 3. Red circles indicate individual data points. Lack of significance compared to CTRL is indicated by n.s.

    Journal: Scientific Reports

    Article Title: Quantitative analysis of Gria1 , Gria2 , Dlg1 and Dlg4 expression levels in hippocampus following forced swim stress in mice

    doi: 10.1038/s41598-019-50689-w

    Figure Lengend Snippet: Forced swim stress does not significantly alter protein levels in hippocampus. ( A ) Hippocampal SAP97, PSD-95, and GluA1 levels relative to β-actin and Gapdh after one (FST1; N = 3 for SAP97 homogenates, N = 10 for all others) or two (FST2; N = 7 for SAP97 synaptoneurosomes, N = 8 for SAP97 homogenates, N = 11 for all others) swim test exposures relative to untreated wild type mice (CTRL; N = 7 for SAP97 homogenates, N = 9 for all others). ( B ) Protein levels (relative to β-actin and Gapdh) in synaptoneurosomal fractions prepared from hippocampal homogenates (CTRL, N = 9; FST1, N = 10; FST2; N = 7–11). Note that differences in sample size are a result of samples being removed when the number of available replicates was below 3. Red circles indicate individual data points. Lack of significance compared to CTRL is indicated by n.s.

    Article Snippet: For staining against SAP97: mouse anti-SAP97 1:500 (NeuroMab K64/15, Lot#75-030), mouse anti-GAPDH 1:10,000 (Sigma-Aldrich G8795, Lot#010M4814), mouse anti-β-actin 1:1,000 (Santa-Cruz sc-47778, Lot#C1510).

    Techniques: